Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor
- PMID: 16868306
- DOI: 10.1152/ajprenal.00480.2005
Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor
Abstract
Epithelial-to-mesenchymal transition (EMT) has emerged as a critical event in the pathogenesis of tubulointerstitial fibrosis. EMT is typically induced by transforming growth factor-beta1 (TGF-beta1) and inhibited by hepatocyte growth factor (HGF). The present study was undertaken to evaluate the potential role of cyclooxygenase (COX)-2-derived PGE2 in regulation of EMT in cultured Madin-Darby canine kidney (MDCK) cells, in the setting of HGF treatment. Exposure to 50 ng/ml HGF significantly induced COX-2 protein expression and PGE2 release, whereas other growth factors, including epidermal growth factor, the insulin-like growth factor I protein, platelet-derived growth factor-BB, and TGF-beta1, had no effects on COX-2 expression or PGE2 release. COX-2 induction by HGF was preceded by activation of ERK1/2, and an ERK1/2-specific inhibitor, U-0126 (10 microM), completely abolished HGF-induced COX-2 expression. Exposure of MDCK cells to 10 ng/ml TGF-beta1 for 72 h induced EMT as evidenced by conversion to the spindle-like morphology, loss of E-cadherin, and activation of alpha-smooth muscle actin. In contrast, treatment with 1 microM PGE2 completely blocked EMT, associated with a significant elevation of intracellular cAMP and complete blockade of TGF-beta1-induced oxidant production. cAMP-elevating agents, including 8-Br-cAMP, forskolin, and IBMX, inhibited EMT and associated oxidative stress induced by TGF-beta1, but inhibition of cAMP pathway with Rp-cAMP, the cAMP analog, and H89, the protein kinase A (PKA) inhibitor, did not block the effect of PGE2. The effect of HGF on EMT was inhibited by approximately 50% in the presence of a COX-2 inhibitor SC-58635 (10 microM). Therefore, our data suggest that PGE2 inhibits EMT via inhibition of oxidant production and COX-2-derived PGE2 partially accounts for the antifibrotic effect of HGF.
Similar articles
-
Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells.Am J Physiol Renal Physiol. 2006 Dec;291(6):F1332-42. doi: 10.1152/ajprenal.00131.2006. Epub 2006 Aug 8. Am J Physiol Renal Physiol. 2006. PMID: 16896186
-
A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.J Am Soc Nephrol. 2005 Jan;16(1):68-78. doi: 10.1681/ASN.2003090795. Epub 2004 Nov 10. J Am Soc Nephrol. 2005. PMID: 15537870
-
Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.J Am Soc Nephrol. 2007 Aug;18(8):2340-9. doi: 10.1681/ASN.2007010128. Epub 2007 Jul 11. J Am Soc Nephrol. 2007. PMID: 17625116
-
The role of tubular epithelial-mesenchymal transition in progressive kidney disease.Cells Tissues Organs. 2007;185(1-3):222-31. doi: 10.1159/000101323. Cells Tissues Organs. 2007. PMID: 17587828 Review.
-
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.Am J Physiol Renal Physiol. 2004 Jul;287(1):F7-16. doi: 10.1152/ajprenal.00451.2003. Am J Physiol Renal Physiol. 2004. PMID: 15180923 Review.
Cited by
-
Therapeutic strategies for synchronous and multiple liver metastases from colorectal cancer.Oncol Rev. 2012 Jun 14;6(1):e9. doi: 10.4081/oncol.2012.e9. eCollection 2012 Mar 5. Oncol Rev. 2012. PMID: 25992211 Free PMC article. Review.
-
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 2010 Jul 1;182(1):73-82. doi: 10.1164/rccm.200905-0674OC. Epub 2010 Mar 4. Am J Respir Crit Care Med. 2010. PMID: 20203246 Free PMC article.
-
Mesenchymal stem cell therapy for attenuation of scar formation during wound healing.Stem Cell Res Ther. 2012 May 31;3(3):20. doi: 10.1186/scrt111. Stem Cell Res Ther. 2012. PMID: 22668751 Free PMC article. Review.
-
The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells.Front Pharmacol. 2018 Jan 31;9:54. doi: 10.3389/fphar.2018.00054. eCollection 2018. Front Pharmacol. 2018. PMID: 29445342 Free PMC article.
-
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.Carcinogenesis. 2008 Nov;29(11):2227-35. doi: 10.1093/carcin/bgn202. Epub 2008 Aug 25. Carcinogenesis. 2008. PMID: 18725385 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous